Chronic Wasting Disease (Cwd) is a progressive neurodegenerative disorder characterized by the gradual loss of neuronal function. This page provides comprehensive information about the disease, including its pathophysiology, clinical presentation, diagnosis, and current therapeutic approaches.
Chronic Wasting Disease (CWD) is a fatal, transmissible spongiform encephalopathy (TSE) caused by misfolded [prion] proteins that affects cervid species including white-tailed deer, mule deer, elk (wapiti), moose, red deer, and reindeer. First identified in captive mule deer in Colorado in the late 1960s and formally described in 1978, CWD has since emerged as the most efficiently transmitted Prion Disease known in any species, spreading relentlessly across North America, Scandinavia, and East Asia 1(https://journals.asm.org/doi/10.1128/mbio.01091-19).
CWD occupies a unique and concerning position among prion diseases due to its extraordinary environmental persistence, efficient horizontal transmission between animals, widespread geographic distribution, and ongoing uncertainty about the potential for cross-species transmission to humans. Unlike [Creutzfeldt-Jakob Disease (CJD)[/diseases/[cjd[/diseases/[cjd[/diseases/[cjd--TEMP--/diseases)--FIX-- in humans or [bovine spongiform encephalopathy (BSE)[/diseases/[bovine-spongiform-encephalopathy[/diseases/[bovine-spongiform-encephalopathy[/diseases/[bovine-spongiform-encephalopathy--TEMP--/diseases)--FIX-- in cattle, CWD spreads readily through direct animal-to-animal contact and environmental contamination, making containment extremely challenging 2(https://www.usgs.gov/centers/nwhc/science/chronic-wasting-disease).
¶ Etiology and Prion Biology
Like all prion diseases, CWD is caused by the misfolding of the normal cellular prion protein (PrP^C) into an abnormal, disease-associated conformation (PrP^CWD or PrP^Sc):
- Normal PrP^C: A glycoprotein expressed on the surface of [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX-- and other cells, with predominant alpha-helical structure. The cervid PRNP gene encodes the prion protein with species-specific polymorphisms that influence susceptibility
- Misfolded PrP^CWD: The disease-associated prion adopts a beta-sheet-rich conformation that is protease-resistant, extremely stable, and capable of templating the conversion of normal PrP^C into the misfolded form
- Self-propagation: PrP^CWD acts as a molecular template, recruiting and converting endogenous PrP^C in a process of seeded polymerization 3(https://pmc.ncbi.nlm.nih.gov/articles/PMC5874178/)
Multiple CWD prion strains have been identified through experimental transmission studies, characterized by:
- Different incubation periods in bioassay animals
- Distinct neuropathological lesion profiles
- Variable biochemical properties (glycoform ratios, electrophoretic mobility)
- Potential differences in host range and zoonotic potential
- At least two major strain types (CWD1 and CWD2) have been identified in North American cervids
The existence of multiple strains has important implications for disease management and risk assessment, as different strains may have different species barrier properties 1(https://journals.asm.org/doi/10.1128/mbio.01091-19).
CWD prions enter the host through multiple routes:
- Oral ingestion: The primary natural route, through consumption of contaminated vegetation, soil, or water
- Mucosal exposure: Contact with saliva, nasal secretions, or urine from infected animals
- Direct contact: Grooming, nuzzling, and other social behaviors facilitate transmission
- Environmental exposure: Prion-contaminated soil, plants, and water sources
Following exposure, CWD follows a stereotypical pathogenic sequence:
- Early lymphoid phase (weeks to months): PrP^CWD first accumulates in gut-associated lymphoid tissue (Peyer's patches, tonsils) and regional lymph nodes
- Lymphoreticular dissemination (months): Spread to spleen, retropharyngeal lymph nodes, and other lymphoid tissues
- Neuroinvasion (months to years): Prions spread via peripheral nerves (vagus nerve, sympathetic fibers) to the [central nervous system]
- CNS propagation (months): Progressive accumulation in the [brainstem[/brain-regions/[brainstem[/brain-regions/[brainstem[/brain-regions/[brainstem--TEMP--/brain-regions)--FIX-- (dorsal motor nucleus of the vagus), [hypothalamus[/brain-regions/[hypothalamus[/brain-regions/[hypothalamus[/brain-regions/[hypothalamus--TEMP--/brain-regions)--FIX--, [thalamus[/brain-regions/[thalamus[/brain-regions/[thalamus[/brain-regions/[thalamus--TEMP--/brain-regions)--FIX--, and [cortex[/brain-regions/[cortex[/brain-regions/[cortex[/brain-regions/[cortex--TEMP--/brain-regions)--FIX--
- Clinical phase (weeks to months): Neuronal loss, spongiform degeneration, and gliosis lead to clinical signs
- Terminal phase: Cachexia, behavioral abnormalities, and death
The incubation period ranges from 16 months to over 5 years, with an average of approximately 2 years in naturally infected deer 2(https://www.usgs.gov/centers/nwhc/science/chronic-wasting-disease).
A critical feature of CWD pathogenesis is the prolonged shedding of infectious prions in body fluids during the preclinical phase:
- Saliva: Infectious prions detectable months before clinical onset
- Urine: Contains low levels of infectivity
- Feces: Significant source of environmental contamination
- Blood: Low-level infectivity present in blood
- Antler velvet: Contains prions during growth phase
This preclinical shedding makes CWD uniquely difficult to control, as apparently healthy animals can be actively transmitting the disease 1(https://journals.asm.org/doi/10.1128/mbio.01091-19).
CWD produces the classic triad of spongiform encephalopathy:
- Spongiform change: Vacuolation of the neuropil, particularly in the [thalamus[/brain-regions/[thalamus[/brain-regions/[thalamus[/brain-regions/[thalamus--TEMP--/brain-regions)--FIX--, [hypothalamus[/brain-regions/[hypothalamus[/brain-regions/[hypothalamus[/brain-regions/[hypothalamus--TEMP--/brain-regions)--FIX--, and [brainstem[/brain-regions/[brainstem[/brain-regions/[brainstem[/brain-regions/[brainstem--TEMP--/brain-regions)--FIX--
- Neuronal degeneration and loss: Progressive loss of [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX-- in affected brain regions
- Astrocytic gliosis: Reactive [astrocytes[/cell-types/[astrocytes[/cell-types/[astrocytes[/cell-types/[astrocytes--TEMP--/cell-types)--FIX-- proliferation with increased [GFAP[/entities/[glial-fibrillary-acidic-protein[/entities/[glial-fibrillary-acidic-protein[/entities/[glial-fibrillary-acidic-protein--TEMP--/entities)--FIX-- expression
- PrP^CWD deposition: Accumulation of disease-associated prion protein in various patterns (diffuse, perineuronal, plaques)
The neuropathological changes in CWD show a characteristic distribution:
- Dorsal motor nucleus of the vagus: Earliest and most consistent CNS involvement
- Obex region: Standard site for diagnostic sampling
- Hypothalamus: Particularly the paraventricular and supraoptic nuclei
- Thalamus: Medial and intralaminar nuclei
- [cortex[/brain-regions/[cortex[/brain-regions/[cortex[/brain-regions/[cortex--TEMP--/brain-regions)--FIX--: Variable involvement depending on species and disease stage
- [cerebellum[/brain-regions/[cerebellum[/brain-regions/[cerebellum[/brain-regions/[cerebellum--TEMP--/brain-regions)--FIX--: Relatively spared compared to some other prion diseases
Clinical CWD presents with a constellation of progressive neurological and systemic signs:
- Weight loss (wasting): Progressive cachexia despite maintained appetite, the most characteristic feature
- Behavioral changes: Loss of fear of humans, listlessness, decreased social interaction, repetitive walking patterns
- Excessive salivation and drooling: Due to swallowing difficulties and esophageal dysfunction
- Polydipsia and polyuria: Increased water intake and urination, likely related to hypothalamic dysfunction
- Ataxia: Incoordination and stumbling, particularly in later stages
- Head tremor: Fine tremor of the head
- Ear drooping: Bilateral ear drooping in some cases
- Aspiration pneumonia: Common terminal complication due to dysphagia
- Death: Invariably fatal, typically within months of clinical onset
The clinical course from onset of signs to death ranges from weeks to several months, with no recovery or remission 2(https://www.usgs.gov/centers/nwhc/science/chronic-wasting-disease).
¶ Transmission and Epidemiology
CWD is the most contagious of all known prion diseases, with highly efficient transmission through:
- Direct horizontal transmission: Animal-to-animal contact (saliva, nasal secretions)
- Indirect environmental transmission: Via contaminated soil, water, and vegetation
- Maternal transmission: Possible vertical transmission, though not well documented
- Iatrogenic transmission: Through contaminated equipment or facilities
CWD prions demonstrate extraordinary environmental stability:
- Soil binding: Prions bind tightly to soil minerals (clay, montmorillonite) and remain infectious for years. Soil-bound prions may actually have enhanced infectivity due to increased stability 4(https://www.usgs.gov/faqs/what-causes-chronic-wasting-disease)
- Plant uptake: Studies have shown that plants can take up prions from contaminated soil through root systems and transport them to stems and leaves, creating another exposure route
- Water contamination: Prions persist in surface water and can bind to sediments
- Resistance to degradation: CWD prions resist standard disinfection methods including formaldehyde, UV radiation, and autoclaving at conventional temperatures
- Carcass contamination: Decomposing carcasses of infected animals create persistent environmental reservoirs
Several animal species may act as vectors for CWD prion dispersal:
- Crows and other scavengers: American crows can excrete viable CWD prions after consuming infected tissue, potentially creating new environmental reservoirs over wide areas
- Coyotes: Scavenging on infected carcasses may spread prions in feces
- Insects: Some evidence suggests that mites or other arthropods could serve as mechanical vectors
As of 2025, CWD has been confirmed in:
- United States: 34 states, with highest prevalence in Colorado, Wyoming, Wisconsin, and the upper Midwest
- Canada: 5 provinces (Alberta, Saskatchewan, Manitoba, Ontario, Quebec)
- Europe: Norway (wild reindeer and moose), Finland (moose), Sweden (moose)
- Asia: South Korea (captive elk imported from Canada)
The continued geographic expansion of CWD, despite surveillance and management efforts, underscores the challenges of controlling an environmentally persistent Prion Disease 5(https://www.cdc.gov/chronic-wasting/animals/index.html).
¶ Zoonotic Potential and Human Health Risk
The potential for CWD to cross the species barrier and infect humans is a major public health concern:
- No confirmed human cases: As of 2025, CWD has not been confirmed to cause disease in humans
- Theoretical risk: The CDC and WHO classify the risk as low but not zero
- Species barrier: Differences between cervid and human [PRNP[/entities/[prnp[/entities/[prnp[/entities/[prnp--TEMP--/entities)--FIX-- sequences create a molecular barrier to cross-species transmission
- Exposure history: Thousands of hunters and their families consume venison from CWD-endemic areas annually
A landmark 2024 study published in Emerging Infectious Diseases (CDC) tested CWD prion transmission to human cerebral organoids — 3D cultures of human brain tissue. The study found no evidence of CWD prion propagation in human brain tissue, supporting the existence of a significant species barrier 6(https://wwwnc.cdc.gov/eid/article/30/6/23-1568_article).
Additional negative evidence includes:
- Failed transmission to transgenic mice expressing human PrP
- No increase in CJD incidence in CWD-endemic regions
- Epidemiological surveillance has not detected novel prion diseases in exposed populations
Despite reassuring experimental results, several factors warrant continued vigilance:
- BSE precedent: The emergence of [variant CJD (vCJD)[/diseases/[variant-cjd[/diseases/[variant-cjd[/diseases/[variant-cjd--TEMP--/diseases)--FIX-- from BSE demonstrated that prion species barriers can be crossed
- Strain evolution: CWD prion strains may adapt through serial passage in different hosts
- Limitations of models: Cerebral organoids and transgenic mice may not fully recapitulate the complexity of natural human exposure
- Long incubation periods: Human prion diseases can have incubation periods exceeding 30 years, meaning current surveillance may miss cases from recent exposures
- Hunter cases: At least two deaths from prion-like illness in hunters who consumed meat from CWD-infected deer populations have raised concern, though causation has not been established 7(https://www.cidrap.umn.edu/chronic-wasting-disease/nih-researchers-never-said-there-no-risk-cwd-spillover-humans)
The CDC recommends:
- Testing harvested deer and elk from CWD-affected areas before consumption
- Not consuming meat from animals that test positive for CWD
- Not consuming meat from animals that appear sick
- Minimizing handling of brain and spinal cord tissue during field dressing
- Wearing gloves when handling potentially infected carcasses
CWD has been documented in a growing number of cervid species and geographic regions (Haley & Bhatt, 2017):
- Susceptible species: White-tailed deer, mule deer, elk (wapiti), moose, red deer, and reindeer/caribou; experimentally transmissible to additional cervid species
- Geographic range: Documented in 32 U.S. states, 5 Canadian provinces, South Korea, Norway (both wild and farmed reindeer), Finland, and Sweden as of 2025
- Transmission: Horizontal transmission via direct contact and environmental contamination (saliva, urine, feces, decomposing carcasses); prions persist in soil for years bound to clay minerals
- Clinical signs: Progressive weight loss (wasting), behavioral changes, excessive salivation, polydipsia, ataxia; incubation period typically 16-36 months
- Prevalence: Varies widely — up to 30-50% in some captive herds; 1-15% in wild populations in endemic areas
- Surveillance: Diagnosis via IHC and ELISA of retropharyngeal lymph nodes or obex; rectal biopsy and PMCA of blood/feces under research investigation (Mathiason et al., 2006)
Wildlife agencies employ several surveillance approaches:
- Hunter-harvested sampling: Mandatory or voluntary submission of head/lymph nodes from harvested deer
- Targeted surveillance: Testing of clinically suspect, road-killed, and found-dead cervids
- Herd testing: Testing captive cervid operations
¶ Management and Control
Controlling CWD in free-ranging wildlife is extremely challenging:
- Herd reduction: Reducing deer density to limit transmission (controversial and of limited efficacy)
- Carcass disposal: Proper disposal of infected carcasses to reduce environmental contamination
- Baiting and feeding bans: Reducing artificial congregation points for cervids
- Carcass transport restrictions: Preventing movement of potentially infected tissues between regions
- Surveillance zones: Intensive monitoring around detection sites
- Mandatory testing: Required CWD testing in captive cervid facilities
- Quarantine protocols: Isolation of herds with detected CWD
- Depopulation: Removal of entire herds in facilities with confirmed CWD
- Interstate movement restrictions: Regulations on transport of captive cervids
The extreme stability of CWD prions makes environmental decontamination challenging:
- Standard autoclaving (121°C, 30 minutes) is insufficient
- Concentrated bleach (40,000 ppm sodium hypochlorite) for 1 hour shows partial efficacy
- 1–2 M NaOH with extended contact time is more effective
- Incineration at >1000°C is the most reliable method
- Soil decontamination remains essentially impossible with current technology
| Feature |
CWD |
[BSE[/entities/[bse[/entities/[bse[/entities/[bse--TEMP--/entities)--FIX-- |
[Scrapie] |
[CJD[/diseases/[creutzfeldt-jakob[/diseases/[creutzfeldt-jakob[/diseases/[creutzfeldt-jakob--TEMP--/diseases)--FIX-- |
[Kuru[/diseases/[kuru[/diseases/[kuru[/diseases/[kuru--TEMP--/diseases)--FIX-- |
| Host |
Cervids |
Cattle |
Sheep/Goats |
Humans |
Humans |
| Transmission |
Horizontal + Environmental |
Feed-borne |
Horizontal + Vertical |
Sporadic/Genetic/Iatrogenic |
Ritualistic cannibalism |
| Environmental persistence |
Very high |
Low |
Moderate |
Minimal |
Minimal |
| Horizontal spread |
Highly efficient |
Not documented |
Moderate |
Not documented |
Not documented |
| Zoonotic potential |
Under investigation |
Confirmed (vCJD) |
Not confirmed |
N/A |
N/A |
| Geographic distribution |
North America, Scandinavia, Korea |
Historically worldwide |
Worldwide |
Worldwide |
Papua New Guinea |
A 2025 paper proposed CWD as a valuable model system for developing and testing prion therapeutics, given its natural occurrence, accessible animal models, and relevance to human prion diseases. The efficient transmission and well-characterized pathogenesis of CWD make it suitable for preclinical testing of anti-prion compounds 8(https://pmc.ncbi.nlm.nih.gov/articles/PMC12118434/).
- Enhanced surveillance and mapping of CWD geographic spread
- Development of rapid, field-deployable diagnostic tests
- Assessment of zoonotic potential through continued experimental and epidemiological studies
- Evaluation of soil and environmental decontamination strategies
- Understanding the molecular determinants of species barriers for CWD prions
- Development of anti-prion therapeutics testable in CWD models
- Assessment of the impact of CWD on cervid population dynamics and ecosystems
- Resolution of the zoonotic risk question through expanded longitudinal cohort studies
- [All Diseases[/[diseases[/[diseases[/[diseases[/[diseases[/[diseases[/diseases
The study of Chronic Wasting Disease (Cwd) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- [Osterholm MT, Anderson CJ, Zabel MD, et al. Chronic Wasting Disease in Cervids: Implications for Prion Transmission to Humans and Other Animal Species. mBio. 2019;10(4]:e01091-19. ASM)
- [U.S. Geological Survey. Chronic Wasting Disease. National Wildlife Health Center. USGS)
- [Bhattacharjee S, Bhattacharya M. Molecular Mechanisms of Chronic Wasting Disease Prion Propagation. Journal of Molecular Biology. 2018;430(22]:4290-4303. PMC)
- [U.S. Geological Survey. What causes chronic wasting disease? USGS)
- [Centers for Disease Control and Prevention. Chronic Wasting Disease in Animals. CDC)
- [Bhatt N, Bhattacharyya M, et al. Lack of Transmission of Chronic Wasting Disease Prions to Human Cerebral Organoids. Emerging Infectious Diseases. 2024;30(6]:1163-1171. CDC)
- [CIDRAP. NIH researchers never said there is no risk of CWD spillover to humans. University of Minnesota. CIDRAP)
- [Bhatt N, et al. Chronic wasting disease as a model for human prion therapy. Prion. 2025;19(1]:2510665. PMC)
- [Centers for Disease Control and Prevention. About Chronic Wasting Disease (CWD]. CDC)
- Saunders SE, Bartelt-Hunt SL, Bartz JC. Occurrence, transmission, and zoonotic potential of chronic wasting disease. Emerging Infectious Diseases. 2012;18(3]:369-376.
- Benestad SL, et al. Chronic wasting disease in Europe. Veterinary Research. 2024;55:86.
- [Haley NJ. Chronic Wasting Disease: Current Assessment of Transmissibility. Current Clinical Microbiology Reports. 2019;6:162-171. PubMed)